Grifols (GRFS) Dividends Paid - Common (2010 - 2020)
Grifols' (GRFS) quarterly Dividends Paid - Common came in at $704.0 million in Q1 2020, up 7.39% YoY from $655.5 million in Q2 2019, and down 19.71% on a QoQ basis from $876.8 million in Q4 2019.
Grifols (GRFS) Dividends Paid - Common (2010 - 2020) Analysis & Trends
Grifols (GRFS) has 11 years of Dividends Paid - Common data on file, last reported at $704.0 million in Q1 2020.
- Quarterly Dividends Paid - Common rose 7.39% year-over-year to $704.0 million in Q1 2020, while the trailing twelve-month figure through Mar 2020 was $2.9 billion (up 145.83% YoY) and the FY2025 annual result came in at $149.0 million, up 13843.31% from the prior year.
- Dividends Paid - Common fell to $704.0 million in Q1 2020, from $876.8 million in the prior quarter.
- In the past five years, Dividends Paid - Common ranged from a high of $1.0 billion in Q1 2018 to a low of -$1.2 billion in Q2 2018.
- A 5-year average of $356.9 million and a median of $664.3 million in 2018 frame the typical range for Dividends Paid - Common.
- Annual changes were most pronounced in 2017 — Dividends Paid - Common surged 187.3% — and 2018, when it sank 67.14%.
- Tracing GRFS's Dividends Paid - Common over 5 years: stood at $334.1 million in 2016, then jumped by 187.3% to $959.7 million in 2017, then plunged by 30.78% to $664.3 million in 2018, then jumped by 31.99% to $876.8 million in 2019, then slipped by 19.71% to $704.0 million in 2020.
- The last three Dividends Paid - Common figures came in at $704.0 million (Q1 2020), $876.8 million (Q4 2019), and $655.5 million (Q1 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 3.23 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 3.07 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 2.14 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 2.87 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 6.58 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 1.36 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 1.03 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 2.45 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | - |
| 10 | Grifols | 5.45 Bn | 4.45 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 703.98 Mn |
| Mar 31, 2020 | 703.98 Mn |
| Dec 31, 2019 | 876.80 Mn |
| Dec 31, 2019 | 876.80 Mn |
| Mar 31, 2019 | 655.51 Mn |
| Mar 31, 2019 | 655.51 Mn |
| Dec 31, 2018 | 664.30 Mn |
| Dec 31, 2018 | 664.30 Mn |
| Jun 30, 2018 | -1.18 Bn |
| Jun 30, 2018 | -1.18 Bn |
| Mar 31, 2018 | 1.04 Bn |
| Mar 31, 2018 | 1.04 Bn |
| Dec 31, 2017 | 959.74 Mn |
| Dec 31, 2017 | 959.74 Mn |
| Jun 30, 2017 | -705.93 Mn |
| Jun 30, 2017 | -705.93 Mn |
| Mar 31, 2017 | 785.51 Mn |
| Mar 31, 2017 | 785.51 Mn |
| Dec 31, 2016 | 334.06 Mn |
| Dec 31, 2016 | 334.06 Mn |